HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Joon Ha Park Selected Research

Neuroprotective Agents

4/2022Astaxanthin Confers a Significant Attenuation of Hippocampal Neuronal Loss Induced by Severe Ischemia-Reperfusion Injury in Gerbils by Reducing Oxidative Stress.
12/2021Hypothermia Induced by Oxcarbazepine after Transient Forebrain Ischemia Exerts Therapeutic Neuroprotection through Transient Receptor Potential Vanilloid Type 1 and 4 in Gerbils.
7/2021Neuroprotective and Anti-Inflammatory Effects of Pinus densiflora Bark Extract in Gerbil Hippocampus Following Transient Forebrain Ischemia.
7/2021Changes in Cyclin D1, cdk4, and Their Associated Molecules in Ischemic Pyramidal Neurons in Gerbil Hippocampus after Transient Ischemia and Neuroprotective Effects of Ischemic Preconditioning by Keeping the Molecules in the Ischemic Neurons.
3/2021Experimental pretreatment with YES-10®, a plant extract rich in scutellarin and chlorogenic acid, protects hippocampal neurons from ischemia/reperfusion injury via antioxidant role.
8/2020Pycnogenol® Supplementation Attenuates Memory Deficits and Protects Hippocampal CA1 Pyramidal Neurons via Antioxidative Role in a Gerbil Model of Transient Forebrain Ischemia.
8/2020Experimental Pretreatment with Chlorogenic Acid Prevents Transient Ischemia-Induced Cognitive Decline and Neuronal Damage in the Hippocampus through Anti-Oxidative and Anti-Inflammatory Effects.
4/2020Laminarin Pretreatment Provides Neuroprotection against Forebrain Ischemia/Reperfusion Injury by Reducing Oxidative Stress and Neuroinflammation in Aged Gerbils.
1/2020YES-10, A Combination of Extracts from Clematis mandshurica RUPR. and Erigeron annuus (L.) PERS., Prevents Ischemic Brain Injury in A Gerbil Model of Transient Forebrain Ischemia.
1/2020Pre-Treatment with Laminarin Protects Hippocampal CA1 Pyramidal Neurons and Attenuates Reactive Gliosis Following Transient Forebrain Ischemia in Gerbils.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Joon Ha Park Research Topics

Disease

89Ischemia
05/2022 - 03/2011
54Transient Ischemic Attack
10/2019 - 03/2011
39Brain Ischemia (Cerebral Ischemia)
09/2021 - 03/2012
18Reperfusion Injury
04/2022 - 07/2013
16Gliosis
01/2021 - 03/2011
12Cognitive Dysfunction
08/2020 - 01/2016
9Heart Arrest (Cardiac Arrest)
10/2021 - 09/2017
8Ischemic Stroke
04/2021 - 01/2013
7Hypothermia
12/2021 - 07/2019
6Hyperthermia
01/2022 - 01/2015
6Inflammation (Inflammations)
10/2021 - 12/2011
5Brain Injuries (Brain Injury)
04/2022 - 01/2018
4Hypoxia (Hypoxemia)
01/2018 - 09/2013
3Amnesia (Dissociative Amnesia)
04/2018 - 06/2017
3Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
01/2017 - 08/2012
2Spinal Cord Injuries (Spinal Cord Injury)
10/2021 - 07/2019
2Neuroinflammatory Diseases
10/2021 - 04/2020
2Paraplegia (Spastic Paraplegia)
10/2021 - 07/2019
2Wounds and Injuries (Trauma)
01/2020 - 01/2014
2Obesity
01/2019 - 12/2018
2Body Weight (Weight, Body)
12/2018 - 09/2014
2Lennox Gastaut Syndrome
04/2018 - 11/2017
2Alzheimer Disease (Alzheimer's Disease)
04/2018 - 01/2018
2Neurodegenerative Diseases (Neurodegenerative Disease)
04/2018 - 02/2017
2Seizures (Absence Seizure)
11/2017 - 09/2016
2Stroke (Strokes)
01/2017 - 05/2013
2Major Depressive Disorder (Major Depressive Disorders)
11/2016 - 11/2015
2Cerebrovascular Disorders (Cerebrovascular Occlusion)
08/2016 - 07/2014

Drug/Important Bio-Agent (IBA)

42salicylhydroxamic acid (SHAM)IBA
01/2022 - 01/2004
41Neuroprotective AgentsIBA
04/2022 - 03/2011
33Proteins (Proteins, Gene)FDA Link
09/2021 - 03/2011
21AntioxidantsIBA
04/2022 - 03/2011
13Glial Fibrillary Acidic ProteinIBA
05/2022 - 03/2011
12CalciumIBA
01/2020 - 03/2011
12Brain-Derived Neurotrophic Factor (BDNF)IBA
06/2019 - 03/2011
11Superoxide DismutaseIBA
04/2022 - 03/2011
11CytokinesIBA
11/2021 - 06/2012
10fluoro jadeIBA
10/2019 - 02/2012
8EnzymesIBA
04/2022 - 11/2015
8Glutathione PeroxidaseIBA
01/2020 - 03/2011
8CatalaseIBA
01/2020 - 03/2011
7Superoxide Dismutase-1IBA
01/2020 - 03/2011
7cresyl violetIBA
10/2019 - 03/2011
7Scopolamine (Hyoscine)FDA Link
04/2018 - 08/2016
6Anticonvulsants (Antiepileptic Drugs)IBA
12/2021 - 12/2015
6Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2021 - 09/2015
5Interleukin-4 (Interleukin 4)IBA
10/2020 - 06/2012
4Risperidone (Risperdal Consta)FDA LinkGeneric
10/2021 - 06/2014
4Interleukin-13IBA
10/2020 - 06/2012
4MelatoninIBA
12/2018 - 06/2016
4tanshinoneIBA
08/2016 - 09/2013
3Oxcarbazepine (Trileptal)FDA LinkGeneric
12/2021 - 10/2019
3Immunoglobulin G (IgG)IBA
11/2021 - 10/2020
3Antipsychotic Agents (Antipsychotics)IBA
10/2021 - 06/2014
3NMDA receptor A1IBA
01/2021 - 02/2013
3Superoxides (Superoxide)IBA
11/2020 - 06/2014
3Myelin Basic ProteinIBA
04/2018 - 01/2016
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2017 - 11/2012
3Glucose (Dextrose)FDA LinkGeneric
06/2017 - 05/2016
3Nuclear Antigens (Extractable Nuclear Antigens)IBA
06/2017 - 03/2011
3Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric
01/2017 - 08/2012
3ThioredoxinsIBA
01/2017 - 05/2012
3Norepinephrine (Noradrenaline)FDA LinkGeneric
11/2016 - 11/2015
3DiterpenesIBA
08/2016 - 12/2012
2Blood Proteins (Serum Proteins)IBA
11/2021 - 07/2017
2AlbuminsIBA
11/2021 - 07/2017
2Transcription Factors (Transcription Factor)IBA
07/2021 - 05/2013
2Heme Oxygenase-1IBA
04/2021 - 01/2018
2Chlorogenic AcidIBA
03/2021 - 08/2020
2Calbindin 1IBA
01/2021 - 06/2017
2laminaranIBA
04/2020 - 01/2020
2Voltage-Gated Sodium ChannelsIBA
04/2020 - 11/2017
2Insulin-Like Growth Factor I (IGF-1)IBA
06/2019 - 01/2014
2Nerve Growth Factors (Neurotrophins)IBA
06/2019 - 01/2014
2Biological ProductsIBA
03/2019 - 10/2015
2fucoidanIBA
01/2019 - 01/2019
2Blood Glucose (Blood Sugar)IBA
12/2018 - 09/2014
2Triglycerides (Triacylglycerol)IBA
12/2018 - 09/2014
2CholesterolIBA
12/2018 - 09/2014
2rufinamideFDA Link
04/2018 - 11/2017
2vanillinIBA
01/2018 - 06/2017
2Ethanol (Ethyl Alcohol)IBA
12/2017 - 02/2013
2Fenofibrate (CiL)FDA LinkGeneric
07/2017 - 02/2016
2Lactic Acid (Lactate)FDA LinkGeneric
06/2017 - 10/2015
2N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
01/2017 - 02/2013
2Duloxetine Hydrochloride (Cymbalta)FDA Link
11/2016 - 11/2015
2Serotonin (5 Hydroxytryptamine)IBA
11/2016 - 11/2015
2LacosamideFDA Link
09/2016 - 12/2015
2ExotoxinsIBA
12/2015 - 04/2012
2GlucokinaseIBA
10/2015 - 12/2013
2glucokinase regulatory proteinIBA
10/2015 - 12/2013
2InterleukinsIBA
09/2015 - 06/2012
2DNA (Deoxyribonucleic Acid)IBA
04/2015 - 01/2013
2Interleukin-2 (IL2)IBA
12/2014 - 06/2012
24-hydroxy-2-nonenal (4-hydroxynonenal)IBA
02/2013 - 06/2011

Therapy/Procedure

5Therapeutics
04/2021 - 09/2016
4Induced Hypothermia
12/2021 - 07/2019
2Cardiopulmonary Resuscitation (CPR)
10/2021 - 07/2019
2Resuscitation
01/2020 - 01/2020
2Transplantation
01/2018 - 12/2016